Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Chemoradiation with Gemcitabine in Borderline Resectable Pancreatic Cancer
NCT01458717Phase 3Completed
- Sponsor
- Seoul National University Hospital
- Start
- Nov 2011
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine in pancreatic cancer (PC), sponsored by Seoul National University Hospital. Started Nov 2011; status: completed.
02
Drugs
gemcitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT01458717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01458717.